These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33155945)

  • 1. Safety of low-dose prolonged infusion of tissue plasminogen activator therapy in patients with thromboembolic events in the intensive care unit.
    Kalkan ME; Yildiz M; Ak HY; Zencirkiran Agus H; Ozsahin Y; Aykan AC; Oksen D
    Kardiologiia; 2020 Aug; 60(7):86-90. PubMed ID: 33155945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism.
    Güner A; Kalçik M; Aykan AÇ; Gürsoy MO; Kalkan AK; Astarcioğlu MA; Ertürk M; Uzun F; Güner EG; Yildiz M; Özkan M
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):536-542. PubMed ID: 33181758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial.
    Özkan M; Gündüz S; Biteker M; Astarcioglu MA; Çevik C; Kaynak E; Yıldız M; Oğuz E; Aykan AÇ; Ertürk E; Karavelioğlu Y; Gökdeniz T; Kaya H; Gürsoy OM; Çakal B; Karakoyun S; Duran N; Özdemir N
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of renal artery thromboembolism with low-dose prolonged infusion of tissue-typed plasminogen activator in a patient with mitral mechanical heart valve thrombosis under the guidance of multimodality imaging.
    Aykan AÇ; Gürsoy OM; Ozkan M; Yildiz M; Kahveci G; Uslu Z
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):663-5. PubMed ID: 22828596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M; Çakal B; Karakoyun S; Gürsoy OM; Çevik C; Kalçık M; Oğuz AE; Gündüz S; Astarcioglu MA; Aykan AÇ; Bayram Z; Biteker M; Kaynak E; Kahveci G; Duran NE; Yıldız M
    Circulation; 2013 Jul; 128(5):532-40. PubMed ID: 23812180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism.
    Kaymaz C; Akbal OY; Keskin B; Tokgoz HC; Hakgor A; Karagoz A; Tanyeri S; Kultursay B; Kulahcioglu S; Dogan C; Bayram Z; Efe SÇ; Erkılınç A; Tanboga IH; Akbulut M; Ozdemir N; Tapson V; Konstantinides S
    Curr Vasc Pharmacol; 2022; 20(4):370-378. PubMed ID: 36324223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].
    Zhao HG; Wang SX; Lu ZN; Yan XX; Lyu ZC; Peng FH; Wu Y; Gao X; Hua L; Jing ZC; Xu XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):314-317. PubMed ID: 28545283
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus.
    Yildiz M; Karakoyun S; Acar RD; Ozkan M
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of prosthetic heart valve thrombosis-derived coronary embolism.
    Karakoyun S; Gürsoy MO; Kalçık M; Yesin M; Özkan M
    Turk Kardiyol Dern Ars; 2014 Jul; 42(5):467-71. PubMed ID: 25080955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
    Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P
    J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolytic agents--who benefits when?].
    Weichert W; Seifried E
    Ther Umsch; 1995 Oct; 52(10):652-60. PubMed ID: 7482376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy of acute pulmonary embolism: current status and future potential.
    Goldhaber SZ; Meyerovitz MF; Markis JE; Kim D; Kessler CM; Sharma GV; Vaughan DE; Selwyn AP; Dawley DL; Loscalzo J
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):96B-104B. PubMed ID: 3117862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-directed thrombolytic intervention is effective for patients with massive and submassive pulmonary embolism.
    Akin H; Al-Jubouri M; Assi Z; Acino R; Sepanski D; Comerota AJ
    Ann Vasc Surg; 2014 Oct; 28(7):1589-94. PubMed ID: 24911801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.
    Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C
    Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [rt-PA in extracardiac thromboembolic vascular occlusions].
    Cortellaro M; Cofrancesco E; Polli EE
    Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Series of Obstructive Prosthetic Mitral Valve Thrombosis, Successfully Treated with Low-Dose, Slow Infusion Tissue-Type Plasminogen Activator.
    Ari H; Dogan A; Ceviker K; Aksoy F; Arslan A; Varol E
    J Heart Valve Dis; 2015 May; 24(3):353-9. PubMed ID: 26901912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.